U.S. Software Stock News

Carpenter Technology earnings and guidance move into focus Carpenter Technology (CRS) has drawn fresh attention after reporting fourth quarter and full year 2026 results, along with new operating income guidance through 2029. This gives investors updated context on profitability and capital allocation. See our latest analysis for Carpenter Technology. Following the earnings release and updated guidance, Carpenter Technology’s share price has eased in the short term, with a 1 day share price...

Theravance Biopharma walked into this earnings print with a flat share price and a reputation built on lumpy royalty income and big one off gains. The stock barely moved today, yet the quarter itself told a quieter story. Core revenue sat at US$20.7m while the company swung to a quarterly loss of US$5.9m as earnings per share slipped back into negative territory. The real headline for you is the gap between rich trailing figures, which still carry that large past gain, and a current quarter...

Omega Healthcare Investors earnings event Omega Healthcare Investors (OHI) recently reported second quarter 2026 results, giving investors fresh detail on how this healthcare focused REIT is performing midway through the year. The report covered sales, revenue, net income and earnings per share for both the quarter and the first six months, offering a broad view of Omega Healthcare Investors financial position. See our latest analysis for Omega Healthcare Investors. At a share price of...

Why Innovative Industrial Properties Stock Is Back in Focus Innovative Industrial Properties (IIPR) recently posted second quarter 2026 earnings with net income and earnings per share higher than a year earlier, despite relatively unchanged revenue. The company also completed a sizeable share buyback. See our latest analysis for Innovative Industrial Properties. The latest earnings and completed buyback have put Innovative Industrial Properties back on investors’ radar, even as the share...

NCR Atleos (NATL) reported second quarter 2026 results on 5 August, with net income and earnings per share above the prior year. Revenue for both the quarter and half year stayed broadly similar. See our latest analysis for NCR Atleos. NCR Atleos shares trade at US$46.86, with a 1 month share price return of 4.3% and a year to date share price return of 25.9%. The 1 year total shareholder return of 27.7% points to momentum building around the earnings improvement story. If you are looking for...

In recent months, Digital Realty Trust has continued to expand its global data center footprint to about 310 facilities with roughly 3.10 gigawatts of IT capacity and 8.50 gigawatts of buildable capacity, while reporting steadily rising core funds from operations that it expects will comfortably cover dividend payments. A key angle for investors is Digital Realty’s emphasis on high-occupancy hyperscale facilities serving cloud and AI customers, which underpins how it aims to benefit from...

Palo Alto Networks has delivered a very large 5 year return, yet its current valuation checks suggest the stock is trading at a premium rather than as an obvious bargain. After a sharp multi year run and recent enthusiasm around AI driven cybersecurity, both market based multiples and an intrinsic value estimate using a Discounted Cash Flow (DCF) approach point to an overvalued picture. Palo Alto Networks has returned roughly 5.3x over 5 years, which sets a high bar for any further upside...

Archer-Daniels-Midland has delivered a 49.8% return over the past five years, yet its valuation signals are mixed, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to upside while earnings based market multiples lean the other way. A 49.8% five year return suggests Archer-Daniels-Midland has already rewarded patient shareholders, so fresh buyers may want to look closely at what is now priced in. Recent investments to expand soybean crush capacity can...

Q2 Holdings (QTWO) stock is in focus after the company reported second quarter 2026 results, with higher sales and net income compared with a year earlier, alongside raised full year revenue and adjusted EBITDA guidance. See our latest analysis for Q2 Holdings. At a share price of $63.36, Q2 Holdings has seen a 22.25% 1 month share price return and a 41.74% 3 month share price return, while the 1 year total shareholder return is down 15.68% and the 5 year total shareholder return is down...

Rocket Lab stock barely moved after earnings, slipping just 0.04% to about $80. That calm surface hides a real sentiment split. Bulls are pointing to record Q2 revenue of $234.1m and a backlog that management pegs at about $2.36b. Bears are focused on the ongoing net loss of $49.3m and the reminder that this is still a cash burning space player. Today's flat trading suggests investors are unsure whether to emphasize the top line results or the profitability challenges that remain. Is Rocket...

BRT Apartments stock barely flinched after earnings, slipping only 0.3% to about US$14, even though the headline story is not about profit at all. For a residential REIT, the real heartbeat is Funds From Operations, and BRT printed roughly US$5.5m in the quarter against a reported net loss of US$3.4m. The market seems to be shrugging because that contrast between cash style earnings and accounting losses is already baked in. The real question for you now is how comfortable you are with that...

SEALSQ (LAES) is back on investors’ radar after appointing Daniel Brau as Chief Quantum Officer, following its full acquisition of Swiss quantum photonics firm Miraex. This move ties leadership directly to its expanding quantum platform ambitions. See our latest analysis for SEALSQ. Despite the quantum-focused announcements in late July and early August, SEALSQ’s share price return is still down about 40% year to date and the 3 year total shareholder return has declined about 72%, which...

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Futu Holdings Limited over past statements on its business operations and regulatory compliance in China, covering investors who bought securities between May 24, 2023 and May 27, 2026. The lawsuit’s focus on alleged misrepresentations around Chinese regulatory compliance could have meaningful implications for how investors assess Futu’s risk profile and disclosures. We’ll now examine how allegations around Futu’s Chinese...

What the new Stripe integration could mean for Synchrony stock Synchrony Financial (SYF) has drawn fresh attention after announcing a new integration with Stripe that brings its CareCredit financing into Stripe’s online checkout for U.S. health and wellness providers. The partnership lets existing and new Stripe health and wellness users activate CareCredit directly in their Stripe Dashboard, without extra integrations. That creates a single hub for payment methods, reporting, reconciliation,...

With the S&P 500 sitting at record levels and trading at 28 times earnings, investors are weighing strong AI driven corporate results against the risk that expectations are set too high. That mix of optimism and unease can create openings that feel easy to miss. This article walks through three large cap stocks from our U.S. index funds screener that are closely tied to this earnings story and explains how today’s setup could matter for your long term portfolio. The three stocks highlighted...

eToro Group walked into this earnings print with sentiment already frayed. The stock was down about 29% over the past three months, then dropped another 14% today to close near US$29. That kind of one day slump suggests traders are reacting emotionally to a softer second quarter revenue line rather than the full picture. The headline is that eToro still produced profitable growth, with Q2 net income of US$53.48m and basic earnings per share of US$0.65 on revenue of US$1.55b. The real question...

AECOM walked into this earnings season wearing the label of an underappreciated infrastructure play with solid long term growth credentials. Today the market slammed the stock anyway. The share price dropped 8.5% to about $67 after the company reported a quarterly loss and booked a heavy $337m pretax charge on a troubled construction management project. For investors, the headline is simple. AECOM just posted a sharp earnings hit driven by one project, while still pointing to record backlog...

Quanterix stock jumped about 8% to US$2.63 after earnings, a sharp move for a company that came into this week with double digit declines over the past month. The market is reacting to a very different story compared with the old high growth diagnostics promise. The headline this quarter is margin and cash discipline. Quanterix posted Q2 revenue of US$32.9 million while reporting a sizeable net loss and cutting full year revenue guidance to a range of US$142 million to US$148 million. The...

Cardinal Health entered this earnings week on a strong run, with the stock already up over the past quarter and edging another 1.3% higher to about US$240 by the close. The market reaction was positive but restrained for a distributor that just printed adjusted free cash flow of US$5.0b and full year revenue of US$254b. That gap between a modest price move and very large cash generation is the real story for you as a shareholder. Is Cardinal Health a rare case where a rich P/E and heavy debt...

Motorcar Parts of America walked into this earnings season with a stock that had drifted down in recent weeks and then barely budged on the print, closing up just 0.2% at US$12.45. That muted move masks a jarring headline. The company swung from a recent quarterly profit to a loss of US$13.4m in Q1 on revenue of US$168.0m. For an auto parts supplier that many investors view as a recovery and margin story, this quarter puts the squeeze in full view. The rest of the year now has to answer...

Oil prices remain sensitive to events in the Middle East, which keeps inflation expectations and defense priorities in focus for governments that rely on energy imports. That backdrop draws attention to companies in the Aerospace and Defense screener, which sit close to major spending decisions. For investors who do not want to sit on the sidelines, this article highlights 3 stocks from the screener that may warrant closer examination. The 3 Aerospace and Defense stocks below are just a...

Accendra Health stock closed at US$1.26, down 10% on the day, as investors reacted to another quarter in the red. The headline is not the revenue line. The real story is the squeeze in profitability, with Q2 basic earnings per share at a loss of US$1.16 and net income excluding extra items also in loss territory. For a home based health provider already dealing with high volatility and balance sheet pressure, that profit strain matters more than the single-day move. The key question now is...

AirSculpt Technologies just jumped 16.9% to about US$3.22, even though this stock has spent the past three months grinding lower. The spark was not a clean return to profits. It was a margin story in a turnaround quarter. Q2 revenue landed at US$42.9 million, while adjusted earnings before interest, tax, depreciation and amortization came in at US$4.9 million with gross margin around 61%. For a business still posting losses, that level of gross profitability is what the market latched onto...

IDEXX Laboratories (NasdaqGS:IDXX) has launched the Catalyst proBNP Test, the first dual-species point-of-care NT-proBNP cardiac assay for companion animals. The new test enables real-time cardiac assessment for both dogs and cats at veterinary clinics. The Catalyst proBNP Test expands IDEXX Laboratories' in-clinic diagnostic menu for cardiac disease in pets. This move into real-time cardiac diagnostics at the clinic level fits into a broader shift toward data driven tools in animal and...